Sn — you need to keep reading .
This is the entire point ,written about in here this week alon—that there are no real competitors to bisantrene.
Bisantrene was better than a country mile compared to nos 2 through 6 etc in the clinical study .
Much better , remarkably so to coin Dr Cullity (RAC Chairman) favourite word . And brequinar , the no 2 compound , was trialed in the past for organ replacement therapy —apart from dangerous immune-suppression actions which makes it unsuited as a cancer treatment drug , it does not have consistent drug dosing regime ability across patients, with wildly varying drug dosages for effects between individual patients and for when negative reactions occur . In short = not good . Known significant problems with the no. 2 FTO inhibitor agent in the COH study , which performed significantly lower than bisantrene anyway.
Other drug compounds — *have not been trialed in people , not even to phase 1 **. So safety unknown, and dose profiles etc are not known , let alone therapeutic effects !
Bisantrene has known safety , and dose regimes are known and understood.
Bisantrene has been through over 40 clinical trials , inc last years Sheba trial ; and most importantly has proven efficacy and effectiveness even in highly refractory cases ..and very advanced cancers(relapsed , not responsive to existing treatments inc anthracyclines resistance ) - which we now realise , that these cancers have associations with FTO protein over -expression
- Forums
- ASX - By Stock
- RAC
- Pillar 1 - FTO (new thread)
Pillar 1 - FTO (new thread), page-403
-
- There are more pages in this discussion • 2,620 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.61 |
Change
-0.045(2.73%) |
Mkt cap ! $273.5M |
Open | High | Low | Value | Volume |
$1.66 | $1.66 | $1.61 | $159.4K | 98.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5684 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5684 | 1.605 |
2 | 1134 | 1.600 |
4 | 5932 | 1.580 |
1 | 6000 | 1.560 |
5 | 6622 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 2000 | 1 |
1.650 | 7731 | 1 |
1.685 | 5000 | 1 |
1.690 | 3316 | 2 |
1.700 | 6580 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online